Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1)Alberto Bresciani, Larry C. Park, Antonino Missineo et al.|Archives of Biochemistry and Biophysics|2017Cited by 45
Identification of Potent and Long-Acting Single-Chain Peptide Mimetics of Human Relaxin-2 for Cardiovascular DiseasesSergio Mallart, Stéphane Illiano, Raffaele Ingenito et al.|Journal of Medicinal Chemistry|2021Cited by 29
Simultaneous Irradiation with UV-A, -B, and -C Lights Promotes Effective Decontamination of Planktonic and Sessile Bacteria: A Pilot StudyAndrea Bosso, Elio Pizzo, Valeria Cafaro et al.|International Journal of Molecular Sciences|2023Cited by 4
Optimization of Single Relaxin B-Chain Peptide Leads to the Identification of R2R01, a Potent, Long-Acting RXFP1 Agonist for Cardiovascular and Renal DiseasesSergio Mallart, Stéphane Illiano, Raffaele Ingenito et al.|Journal of Medicinal Chemistry|2025Cited by 1